Ribon Therapeutics logo

Ribon Therapeutics

Cancer drugs that target specific types of poly ADP-ribose polymerase

3

Funding Rounds

$190.2m

Money raised

Overview

Cancer drugs that target specific types of poly ADP-ribose polymerase

Funding

Funding series

Funding Series Analysis

The company Ribon Therapeutics has raised a total of $130m in funding over 3 rounds.

Key Insights:

  • Ribon Therapeutics , July 2021: $65m
  • Ribon Therapeutics Series B round, January 2018: $65m
  • Ribon Therapeutics, Inc. funding round, June 2021: $60.15m
Ribon Therapeutics logo
Ribon Therapeutics , July 2021 $65m
Ribon Therapeutics logo
Ribon Therapeutics Series B round, January 2018 $65m
Ribon Therapeutics logo
Ribon Therapeutics, Inc. funding round, June 2021 $60.15m